Success Metrics

Active Trials
10(67%)

Phase Distribution

Ph phase_1
6
40%
Ph phase_3
4
27%
Ph phase_2
5
33%

Phase Distribution

6

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
6(40.0%)
Phase 2Efficacy & side effects
5(33.3%)
Phase 3Large-scale testing
4(26.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

10

trials recruiting

Total Trials

15

all time

Status Distribution
Active(14)
Terminated(1)

Detailed Status

Recruiting9
Not yet recruiting4
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
10
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 16 (40.0%)
Phase 25 (33.3%)
Phase 34 (26.7%)

Trials by Status

not_yet_recruiting427%
active_not_recruiting17%
withdrawn17%
recruiting960%

Recent Activity

10 active trials
Showing 5 of 15
active_not_recruitingphase_3

Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure

NCT06935409
not_yet_recruitingphase_3

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

NCT07464327
recruitingphase_1

Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors

NCT07186452
recruitingphase_1

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

NCT07115446
not_yet_recruitingphase_1

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

NCT06963502
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06935409Phase 3

Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure

Active Not Recruiting
NCT07464327Phase 3

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Not Yet Recruiting
NCT07186452Phase 1

Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors

Recruiting
NCT07115446Phase 1

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

Recruiting
NCT06963502Phase 1

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors

Not Yet Recruiting
NCT06825624Phase 1

ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer

Recruiting
NCT06112704Phase 2

HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors

Recruiting
NCT06699576Phase 1

ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.

Not Yet Recruiting
NCT06498479Phase 3

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Recruiting
NCT05830123Phase 2

ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

Recruiting
NCT06001255Phase 2

ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Recruiting
NCT06007729Phase 2

ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Recruiting
NCT06526624Phase 3

A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer

Not Yet Recruiting
NCT06332170Phase 1

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

Recruiting
NCT06052423Phase 2

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Withdrawn

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15